Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Antiviral Research|September 20, 2011
In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infectionsYohichi Kumaki, Craig W Day, Donald F Smee, et al.
Future Virology|February 25, 2014
Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in miceDonald F Smee, E Bart Tarbet, Yousuke Furuta, et al.
Antiviral Research|October 20, 2006
Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster modelJustin G Julander, John D Morrey, Lawrence M Blatt, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Phosphorothioate di- and trinucleotides as a novel class of anti-hepatitis B virus agentsRadhakrishnan P Iyer, Yi Jin, Arlene Roland, et al.
Antiviral Research|May 20, 2014
The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infectionJustin G Julander, Kyle Kesler, Arnaud J Van Wettere, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2009
Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in miceDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
The American Journal of Pathology|January 30, 2018
Comparative Histopathologic Lesions of the Male Reproductive Tract during Acute Infection of Zika Virus in AG129 and Ifnar<sup>-/-</sup> MiceChad S Clancy, Arnaud J Van Wettere, Venkatraman Siddharthan, et al.
Antiviral Research|January 8, 2014
Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal modelJustin G Julander, Brett A Thibodeaux, John D Morrey, et al.
Antimicrobial Agents and Chemotherapy|April 29, 2009
Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivoJohn D Morrey, Brent E Korba, James R Beadle, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
A porphyrin increases survival time of mice after intracerebral prion infectionDavid A Kocisko, Winslow S Caughey, Richard E Race, et al.
Pageof 10